Stocks Rise as Earnings, Vaccine Developments Hit

Credit: The Street

Duration: 02:26s 20 Oct 2020 0 shares 1 views

Stocks Rise as Earnings, Vaccine Developments Hit

Moderna CEO Stephane Bancel said the U.S. government could authorize emergency use of the company's experimental Covid-19 vaccine by December.

You might like

Related news coverage

Moderna Gets a Shot From Pre-Sales of its Covid-19 Vaccine

Moderna Gets a Shot From Pre-Sales of its Covid-19 Vaccine

The Street 29 Oct 2020

Moderna third-quarter earnings fall but sales jump as governments around the world place pre-orders for its yet-to-be approved..

Vaccine News Plus Earnings Push Stocks Higher: What Wall Street's Saying

Vaccine News Plus Earnings Push Stocks Higher: What Wall Street's Saying

The Street

20 Oct 2020

Wall Street closes lower on vaccine delay

Wall Street closes lower on vaccine delay

Reuters Studio

13 Oct 2020

Wall Street Tumbles As Investors Just Weren't Happy About Anything

Wall Street Tumbles As Investors Just Weren't Happy About Anything

Wochit Business

13 Oct 2020

Jim Cramer: JNJ Shouldn't Be Trading Off of its Vaccine Trial, But Rather its Earnings

Jim Cramer: JNJ Shouldn't Be Trading Off of its Vaccine Trial, But Rather its Earnings

The Street

13 Oct 2020

Advertisement

More coverage

Solid Earnings for JNJ Offset Covid-19 Vaccine Trial Setback

Solid Earnings for JNJ Offset Covid-19 Vaccine Trial Setback

Johnson & Johnson posts strong third-quarter results and boosts guidance on the same day it announces a pause in its Covid-19..

The Street 13 Oct 2020